Year |
Citation |
Score |
2003 |
Brittsan AG, Ginsburg KS, Chu G, Yatani A, Wolska BM, Schmidt AG, Asahi M, MacLennan DH, Bers DM, Kranias EG. Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport. Circulation Research. 92: 769-76. PMID 12637367 DOI: 10.1161/01.Res.0000066661.49920.59 |
0.599 |
|
2001 |
Haghighi K, Schmidt AG, Hoit BD, Brittsan AG, Yatani A, Lester JW, Zhai J, Kimura Y, Dorn GW, MacLennan DH, Kranias EG. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. The Journal of Biological Chemistry. 276: 24145-52. PMID 11328820 DOI: 10.1074/Jbc.M102403200 |
0.698 |
|
2000 |
Brittsan AG, Kranias EG. Phospholamban and cardiac contractile function. Journal of Molecular and Cellular Cardiology. 32: 2131-9. PMID 11112989 DOI: 10.1006/Jmcc.2000.1270 |
0.59 |
|
2000 |
Brittsan AG, Carr AN, Schmidt AG, Kranias EG. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. The Journal of Biological Chemistry. 275: 12129-35. PMID 10766848 DOI: 10.1074/Jbc.275.16.12129 |
0.639 |
|
1999 |
Brittsan AG, Kiss E, Edes I, Grupp IL, Grupp G, Kranias EG. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions. Journal of Molecular and Cellular Cardiology. 31: 1725-37. PMID 10471356 DOI: 10.1006/Jmcc.1999.1010 |
0.617 |
|
1999 |
Haghighi K, Hoi BD, Schmidt A, Kimura Y, Brittsan AG, MacLennan DH, Kranias EG. Cardiac overexpression of a mutant form of phospholamban is associated with depressed contractility and hypertrophy Journal of Cardiac Failure. 5: 11. DOI: 10.1016/S1071-9164(99)91386-6 |
0.594 |
|
1998 |
Kiss E, Brittsan AG, Edes I, Grupp IL, Grupp G, Kranias EG. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. Circulation Research. 83: 608-13. PMID 9742056 DOI: 10.1161/01.Res.83.6.608 |
0.684 |
|
1998 |
Brittsan AG, Kadambi VJ, Hoit BD, Kranias EG. Cardiac overexpression of a non-phosphorylatable form of phospholamban results in depressed contractile function and hypertrophy Journal of Cardiac Failure. 4: 20. DOI: 10.1016/S1071-9164(98)90072-0 |
0.597 |
|
Show low-probability matches. |